ANGIOTENSIN RECEPTOR GENES AND BLOOD PRESSURE REGULATION
血管紧张素受体基因和血压调节
基本信息
- 批准号:2857874
- 负责人:
- 金额:$ 20.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-01-01 至 1999-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: The renin-angiotensin system (RAS) plays a critical role in
regulating blood pressure and sodium balance and these actions are mediated
through angiotensin type I (AT1) receptors. In the kidney, the RAS acts
through three distinct pathways that may influence sodium handling: (1)
hemodynamic effects at the level of the glomerular circulation mediated by
ATl receptors on renal vasculature (2) direct effects on sodium transport
modulated by ATl receptors expressed on proximal tubular epithelial cells
(3) regulation of sodium reabsorption in the distal nephron by aldosterone
under the control of ATl receptors in the adrenal cortex. In the mouse, two
separate ATl receptor genes control these functions: AgtrlA and AgtrlB.
Using mouse models in which expression of these ATl receptor genes has been
specifically altered using gene targeting, it is proposed to determine the
role of ATl angiotensin receptor genes in regulating blood pressure through
the following specific aims: Specific Aim I: To define the role of the
ATlA receptor in renal adaptation to altered dietary sodium intake, the
hypothesis that abnormal renal sodium handling contributes to sodium
dependent blood pressure changes in the AgtrlA (-/-) mice will be studied.
Specific Aim II: To examine the role of renal AgtrlA expression in the
regulation of blood pressure, the contribution of renal ATlA receptors to
the control of blood pressure in renal cross transplantation experiments
between AgtrlA (+/+) and AgtrlA (-/-) mice will be determined. Specific Aim
III: To determine the contribution of renal epithelial actions of
angiotensin II to blood pressure and sodium homeostasis transgenic mice that
express the ATlA receptor in the kidney only on epithelial cells in the
proximal tubule will be developed. Specific Aim IV: To determine the role
of AT1B receptors in blood pressure regulation in AgtrlA (-/-) mice, RAS
regulation by dietary sodium, and blood pressure responses will be studied
when AT1B receptors are inhibited or absent. Specific Aim V: To define the
contribution of the AgtrlB gene to blood pressure regulation, mice with
targeted disruption of the AgtrlB gene will be studied.
肾素-血管紧张素系统(RAS)在
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS M COFFMAN其他文献
THOMAS M COFFMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS M COFFMAN', 18)}}的其他基金
Paracrine Control of Blood Pressure by Renal Intercalated Cells
肾闰细胞对血压的旁分泌控制
- 批准号:
9070607 - 财政年份:2015
- 资助金额:
$ 20.45万 - 项目类别:
George M. O'Brien Kidney Research Core Centers
乔治·M·奥布莱恩肾脏研究核心中心
- 批准号:
8385010 - 财政年份:2012
- 资助金额:
$ 20.45万 - 项目类别:
George M. O'Brien Kidney Research Core Centers
乔治·M·奥布莱恩肾脏研究核心中心
- 批准号:
8912150 - 财政年份:2012
- 资助金额:
$ 20.45万 - 项目类别:
George M. O'Brien Kidney Research Core Centers
乔治·M·奥布莱恩肾脏研究核心中心
- 批准号:
8529521 - 财政年份:2012
- 资助金额:
$ 20.45万 - 项目类别:
Genetic Determinants of Susceptibility to Kidney Disease in African Americans
非裔美国人肾病易感性的遗传决定因素
- 批准号:
7936333 - 财政年份:2009
- 资助金额:
$ 20.45万 - 项目类别:
Genetic Determinants of Susceptibility to Kidney Disease in African Americans
非裔美国人肾病易感性的遗传决定因素
- 批准号:
7820192 - 财政年份:2009
- 资助金额:
$ 20.45万 - 项目类别:
ANGIOTENSIN RECEPTORS/PROSTAGLANDIN E2-REGIONAL BLOOD FLOW IN MOUSE KIDNEY
血管紧张素受体/前列腺素 E2 小鼠肾脏区域血流
- 批准号:
7726151 - 财政年份:2008
- 资助金额:
$ 20.45万 - 项目类别:
G-PROTEIN PATHWAYS IN THE KIDNEY TRANSPLANT REJECTION
肾移植排斥反应中的 G 蛋白途径
- 批准号:
7486792 - 财政年份:2007
- 资助金额:
$ 20.45万 - 项目类别:
相似海外基金
Exploratory Efficacy-Evaluation Study of Angiotensin Receptor-Neprilysin Inhibitor in patients with dialysis
血管紧张素受体脑啡肽酶抑制剂在透析患者中的探索性疗效评价研究
- 批准号:
21K16191 - 财政年份:2021
- 资助金额:
$ 20.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Personalizing Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Chronic Kidney Disease
慢性肾脏病的个体化血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂治疗
- 批准号:
10313873 - 财政年份:2021
- 资助金额:
$ 20.45万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10469311 - 财政年份:2020
- 资助金额:
$ 20.45万 - 项目类别:
Impact of an Angiotensin Receptor Blocker in Aortic Stenosis - a Randomized Controlled Trial
血管紧张素受体阻滞剂对主动脉瓣狭窄的影响 - 一项随机对照试验
- 批准号:
433568 - 财政年份:2020
- 资助金额:
$ 20.45万 - 项目类别:
Operating Grants
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10649490 - 财政年份:2020
- 资助金额:
$ 20.45万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10210299 - 财政年份:2020
- 资助金额:
$ 20.45万 - 项目类别:
Strategies for Angiotensin Receptor Blocker Mediated Tissue Repair
血管紧张素受体阻滞剂介导的组织修复策略
- 批准号:
10065083 - 财政年份:2020
- 资助金额:
$ 20.45万 - 项目类别:
Mechanism of suppressive effects for atherosclerosis by Angiotensin Receptor-Neprilysin Inhibitor
血管紧张素受体脑啡肽酶抑制剂抑制动脉粥样硬化的机制
- 批准号:
19K17618 - 财政年份:2019
- 资助金额:
$ 20.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathophysiological significance of angiotensin receptor-binding protein in leucocytes and immune cells
白细胞和免疫细胞中血管紧张素受体结合蛋白的病理生理意义
- 批准号:
19K17575 - 财政年份:2019
- 资助金额:
$ 20.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control
AgRP 神经元中血管紧张素受体 G 蛋白信号转换在心脏代谢控制中的作用
- 批准号:
10658260 - 财政年份:2017
- 资助金额:
$ 20.45万 - 项目类别:














{{item.name}}会员




